Department of Neurology, Philipps-University, Marburg, Germany.
Pain. 2013 Aug;154(8):1457-63. doi: 10.1016/j.pain.2013.05.007. Epub 2013 May 10.
Pain and other sensory signs in patients with restless legs syndrome (RLS) are still poorly understood, as most investigations focus on motor system dysfunctions. This study aimed to investigate somatosensory changes in patients with primary RLS and the restoration of somatosensory function by guideline-based treatment. Forty previously untreated RLS patients were investigated unilaterally over hand and foot using quantitative sensory testing (QST) and were compared with 40 age- and gender-matched healthy subjects. The predominant finding in RLS patients was 3- to 4-fold increase of sensitivity to pinprick stimuli in both extremities (hand: P<.05; foot: P<.001), a sensory pathway involved in withdrawal reflexes. Pinprick hyperalgesia was not paralleled by dynamic mechanical allodynia. Additional significant sensory changes were tactile hypoesthesia in both extremities (hand: P<.05; foot P<.01) and dysesthesia to non-noxious cold stimuli (paradoxical heat sensation), which was present in the foot in an unusually high proportion (14 of 40 patients; P<.01). In 8 patients, follow-up QST 2 to 20 months after treatment with l-DOPA (L-3,4-dihydroxyphenylalanine) revealed a significant reduction of pinprick hyperalgesia (-60%, P<.001), improved tactile detection (+50%, P<.05), and disappearance of paradoxical heat sensation in half of the patients. QST suggested a type of spinal or supraspinal central sensitization differing from neuropathic pain or human experimental models of central sensitization by the absence of dynamic mechanical allodynia. Reversal of pinprick hyperalgesia by l-DOPA may be explained by impaired descending inhibitory dopaminergic control on spinal nociceptive neurons. Restoration of tactile sensitivity and paradoxical heat sensations suggest that they were functional disturbances resulting from central disinhibition.
原发性不安腿综合征患者的疼痛及其他感觉征象仍知之甚少,因为大多数研究都集中在运动系统功能障碍上。本研究旨在调查原发性不安腿综合征患者的躯体感觉变化,以及基于指南的治疗对躯体感觉功能的恢复情况。我们对 40 例未经治疗的不安腿综合征单侧上肢和下肢患者进行了定量感觉测试(QST),并与 40 名年龄和性别匹配的健康对照者进行了比较。不安腿综合征患者的主要发现是四肢的刺痛感觉敏感性增加 3-4 倍(上肢:P<.05;下肢:P<.001),这是一种涉及回避反射的感觉通路。刺痛性痛觉过敏与动态机械性触诱发痛不同。其他显著的感觉变化包括四肢的触觉感觉减退(上肢:P<.05;下肢:P<.01)和非伤害性冷刺激的感觉异常(反常热感觉),后者在足部的发生率异常高(40 例患者中有 14 例;P<.01)。在 8 例患者中,在 l-DOPA(L-3,4-二羟基苯丙氨酸)治疗后 2 至 20 个月进行了 QST 随访,发现刺痛性痛觉过敏显著降低(-60%,P<.001),触觉检测改善(+50%,P<.05),一半患者的反常热感觉消失。QST 提示一种不同于神经病理性疼痛或人类中枢敏化实验模型的脊髓或脊髓上中枢敏化类型,其特点是缺乏动态机械性触诱发痛。l-DOPA 逆转刺痛性痛觉过敏可能是由于下降的抑制性多巴胺能对脊髓伤害性神经元的控制受损所致。触觉敏感性和反常热感觉的恢复表明它们是中枢去抑制引起的功能障碍。